Back HIV Populations Women & HIV

Women & HIV

HIV+ Women May Experience More Severe Menopause Symptoms

Women with HIV on average experience more severe hot flashes around the time of menopause than HIV negative women, and they interfere more with daily life, according to a study described in the July 1, 2013, advance online edition of the journal Menopause.

alt

Read more:

GRACE Survey Sheds Light on Treatment Benefits and Barriers for HIV+ Women

Caring for children, unemployment, and transportation difficulties were among the factors most likely to lead to poor adherence, early dropout, and suboptimal response to antiretroviral therapy (ART) among participants in the GRACE trial, which tested darunavir (Prezista) in a study population consisting largely of women of color. Overall, they said participation was a positive experience and they would encourage others to join a clinical trial.

alt

Read more:

March 10 Is National Women and Girls HIV/AIDS Awareness Day

Sunday is National Women and Girls HIV/AIDS Awareness Day (NWGHAAD), an annual opportunity to call attention to the burden of HIV and AIDS among women and girls worldwide.

According to the U.S. Centers for Disease Control and Prevention (CDC), women and adolescent girls (aged 13 and older) accounted for 21% of the nearly 50,000 new HIV diagnoses in the U.S. in 2011. The CDC estimates that just over 279,000 women and girls were living with HIV at the end of 2009 -- including 15% who are not aware they are infected.

alt

Read more:

New Advocacy Group Wants to Improve Feasibility of PrEP for U.S. Women

Following disappointing results from the VOICE trial released at the recent 20th Conference on Retroviruses and Opportunistic Infections (CROI) in Atlanta, a new U.S. Women and PrEP Working Group has called on the federal government to help American women use antiretroviral pre-exposure prophylaxis (PrEP) safely and effectively. But the AIDS Healthcare Foundation (AHF) responded by urging the Food and Drug Administration to rescind its approval of Truvada (tenofovir/emtricitabine) for HIV prevention.

alt

Read more:

U.S. Conference on AIDS Underway this Week in Las Vegas

The U.S. Conference on AIDS (USCA), one of the major meetings focused on the domestic HIV/AIDS epidemic in the United States, is taking place this week in Las Vegas. Among the major themes are advances in HIV prevention, disparities in HIV epidemiology and access to care, implementation of the National HIV/AIDS Strategy, and how healthcare reform will affect people with HIV. Follow blog.Aids.gov for reports throughout the conference. alt

Read more: